Bisoprolol Fumarate NDC 16714-530

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-530Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0530Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-530-01	16714053001	30 TABLET, FILM COATED in 1 BOTTLE (16714-530-01)Marketed from Dec 27, 2006
16714-530-02	16714053002	100 TABLET, FILM COATED in 1 BOTTLE (16714-530-02)Marketed from Dec 27, 2006

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bisoprolol Fumarate
Generic name (nonproprietary): bisoprolol fumarate
Active ingredients: Bisoprolol fumarate — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: NorthStar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077910
Marketing start: Dec 27, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 16714-530_169e7bf6-19d7-4dc5-bfc7-35c5a8e4cf18SPL ID 169e7bf6-19d7-4dc5-bfc7-35c5a8e4cf18SPL set ID 4bf3278c-116f-4db7-9af0-08faaf7691a4RxCUI 854901, 854905UNII UR59KN573L
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714053001 followed by a unit qualifier and the quantity

Package 16714-0530-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 5, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Bisoprolol fumarate tablets are indicated in the management of hypertension. They may be used alone or in combination with other antihypertensive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077910

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077910
Product	Strength	Form · route	Labeler	Product NDC
Bisoprolol Fumarate	Bisoprolol fumarate 5 mg/1	Tablet, Film coatedOral	NorthStar Rx LLC	16714-529
Bisoprolol Fumarate	Bisoprolol fumarate 5 mg/1	Tablet, Film coatedOral	AvPAK	50268-127
Bisoprolol Fumarate	Bisoprolol fumarate 5 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-086
Bisoprolol Fumarate	Bisoprolol fumarate 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-087